People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Venus Concept Inc. | — | Other Health Care | Series C | $194.2M | $9.8M | 2011 |
| Second Sight Medical Products Inc | — | Biotechnology | Series B | $130.9M | $807.7M | 2012 |
| Blockade Medical, LLC | — | Other Health Care | Series A | $12.7M | $47.8M | 2015 |
TOM FOGARTY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TOM FOGARTY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 1 | 16 |
| Craig Taylor | 1 | 13 |
| William Link | 1 | 11 |
| Frederic Moll | 1 | 10 |
| FRED MOLL | 1 | 8 |
| JEFF BIRD | 1 | 7 |
| William Kelley | 1 | 6 |
| Robert Greenberg | 1 | 6 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Emmett Cunningham | 1 | 4 |
| David Ferrera | 1 | 4 |
| Anthony Natale | 1 | 4 |
| Scott Barry | 1 | 4 |
| DOUG KELLY | 1 | 4 |
| James McCollum | 1 | 3 |
| Brent Nixon | 1 | 3 |
| Shelley Thunen | 1 | 3 |
| Gilbert Clarke | 1 | 3 |
| Gil Kliman | 1 | 3 |
| Domenic Serafino | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.